Building the future
of
medical cannabis in
Latin
America.
Costa Rica's first multinational medical cannabis company — fully licensed and vertically integrated — delivering pharmaceutical-grade products to patients worldwide.
Cultivating Wellness in
Latin America.
At Canna Pura Vida, our mission is simple: Cultivate Wellness in Latin America.
We are building Costa Rica's first multinational medical cannabis company — fully licensed and vertically integrated — delivering pharmaceutical-grade cannabis products to patients worldwide.
Our vision fuses the world-renowned "Pura Vida" lifestyle with medical premium care, ensuring that every product we produce is consumer-tier ready. By combining advanced cultivation techniques, rigorous regulatory compliance, and a tropical training model, we're positioning Canna Pura Vida as the undisputed leader in Latin America's medical cannabis market.
360° vertical integration with all
key licenses.
We own 7.1 hectares of strategic land in Santa Teresa, Puntarenas, with a 6000 m² site licensed and ready for construction of our GMP-compliant cultivation and manufacturing facility — also designated as a Free-Zone Area.
Importation
Importer licenses for raw materials, equipment, and high-grade genetics.
Manufacturing
cGMP-class facility designed for production of pharmaceutical-grade products.
Cultivation
7.1 hectares of state-licensed commercial cannabis cultivation capacity.
Pharmacy Chains
15 Canna Pura Vida cannabis pharmacies in strategic locations across Costa Rica.
Tissue Culture & Genetics
Tissue Culture technology and genetic development of unique cannabis strains.
Traceability
BlocPACT integration for end-to-end tracking of the entire process.
Multinational presence across
Latin America.
Costa Rica — Headquarters
Premiere operations in Santa Teresa, cultivation, commercial lab, manufacturing, plus 15 pharmacies nationwide.
Panama — First Mover
Import licenses and one active pharmacy and cultivation facility for downstream distribution.
Colombia — Supply Hub
Strategic supply chain of biological raw cultivation capacity. Agronomic powerhouse for the region.
Pharmacy Locations
During 2025 and 2026, Canna Pura Vida will open nine retail locations every month to reach a total of 15 pharmacies branded Canna Pura Vida by 2026.
Our expansion plan logic is high-profile locations across the country's most strategic provinces and tourist centers within the first 18 months of cooled and full implementation.
Serving both the local market and the 70,000 annual medical tourists that visit Costa Rica.
16
Pharmacies By 2027
70K
Medical Tourists
Building the Future of Medical
Cannabis in LATAM.
A region ready for leadership — a fully vertical company across the entire value chain. Next Big Crop in cultivation, Adelisa in pharma innovation, Adelisa in distribution, and strategic alliances with CAJA, CCSS, MUT-TEC, and ULACIT.
Proven Track Record
30+ years of cannabis industry experience in the US, applied to Costa Rica, Panama, and Colombia.
Cultivation Excellence
Commercial-class operations under cGMP standards, producing consistent pharmaceutical-grade flower and extracts.
Genetic Leadership
Best-in-class tissue culture technology, breeding pure flora, pathogen-free, plant-essential cultivation industry-set capabilities.
Vertical Integration
From cultivation to broad-product manufacturing and retail pharmacies, ensuring high margins at every stage.
Strategic Retail Locations
Flagship dispensary placement in high-demand markets strengthening brand equity and acquisition.
A Unique Opportunity
Canna Pura Vida is uniquely positioned to become the leading medical cannabis operator in Latin America.
Ready to be part of the future?
Learn about our investment opportunities or schedule a medical alignment with our team.